<DOC>
	<DOC>NCT00550576</DOC>
	<brief_summary>Subjects suffering from bipolar disorders treated with specific medications will give their informed concent and will receive intravenously only one dose of Digoxin antibodies (Fab). Their response to this therapy will be measured accordingly.Previous medications will be not changed A base line serum Endogenous Digitalis-like Compounds (DLC)levels will be measured using a specific laboratory technique and these compounds will be measured at 6 and 24 hours after Fab therapy. Patients also will be followed using clinical and psychological tests</brief_summary>
	<brief_title>Antibodies to Digoxin for Bipolar Disorder</brief_title>
	<detailed_description>Twenty subjects suffering from bipolar disorders treated with specific medications will give their informed concent and will included in the study. All will receive in an open study only one intravenously dose of Digoxin antibodies (Fab). Their response to this therapy will be measured accordingly.Previous medications will be not changed A base line serum Endogenous Digitalis-like Compounds (DLC)levels will be measured using a specific laboratory technique and these compounds will be measured at 6 and 24 hours after Fab therapy. Patients also will be followed using clinical and psychological tests</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Admitted patients suffering from Bipolar Disorder abillity to give informed concent Allergy to Digoxin Antibodies Renal and Liver function impairment Liver Cirrhosis Asthma Patients on Digoxin or Digitoxin Patients receiving Aldactone therapy Heart AV Block Hypo or Hyperkalemia on admission Potential Suicidal Behaviour</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Digoxin Antibodies</keyword>
	<keyword>Bipolar Disorder</keyword>
</DOC>